Janux Therapeutics

JANX

NASDAQHealth Care

Income Statement

Total Revenue$10.59M

Gross Profit$10.59M

Operating Income$-98.85M

EBITDA$-66.93M

EBIT$-68.99M

Pre-tax Income$-105.64M

Net Income$-68.99M

Cash Equivalent$172.02M

Total Debt$23.62M

Book Value$748.08M

Book Value Per Share14.38

Return on Equity (ROE)-6.74%

Return on Assets (ROA)-6.50%

Return on Invested Capital (ROI)-6.74%

Net Profit Margin-651.62%

Current Ratio60.82

Quick Ratio60.32

Long-Term Debt / Equitynull